⚕ GalenOps CRO console
← 718 (USA)

718-1254

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 718 (USA) (Dr. Nolan) · consented 2013-07-10
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate APPLICATION SITE DISCOLOURATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-13 (study day 35.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-13 (study day 35.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-13 (study day 4.0); relationship: NONE

mild assessed 2026-08-18

Mild ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-25 (study day 16.0); relationship: NONE

mild assessed 2026-08-18

Mild ARTHRALGIA — outcome: RECOVERED/RESOLVED; onset 2013-07-25 (study day 16.0); relationship: NONE

moderate assessed 2026-08-18

Moderate DYSPHAGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 114.0); relationship: not assessed

moderate assessed 2026-08-18

Moderate FOOD CRAVING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 114.0); relationship: not assessed

moderate assessed 2026-08-18

Moderate SOMNOLENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-03 (study day 56.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate SOMNOLENCE — outcome: RECOVERED/RESOLVED; onset 2013-09-03 (study day 56.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.